Targeting NF-κB protein levels (87, 88) or inhibiting its activity (89) can reduce AEC inflammatory injury and alleviate bacterial Sepsis-Associated ALI. This evidence concerns the gene NFKB1 and bacterial infectious disease with sepsis.